Table of contents

01 - Pre-Meeting Briefing prepared by NICE

02 - Submission from the technology manufacturer - Gilead Sciences

03 - NICE request to the manufacturer for clarification on their submission

04 - Manufacturer clarification response

05 - Consultee submission - Chronic Lymphocytic Leukaemia Support Association

06 - Consultee submission - Leukaemia CARE

07 - Consultee submission - Lymphoma Association

08 - Clinical expert personal perspective - Fegan

09 - Clinical expert personal perspective - Forconi

10 - Patient expert personal perspective - Gardom

11 - Patient expert personal perspective - York

12 - Evidence Review Group report prepared by Warwick Evidence

13 - Manufacturer factual accuracy check of Evidence Review Group report

14 - Evidence Review Group report erratum prepared by Warwick Evidence